150 related articles for article (PubMed ID: 14512678)
1. Fluorodeoxyglucose PET scan in pulmonary sarcoidosis during treatment with inhaled and oral corticosteroids.
Milman N; Mortensen J; Sloth C
Respiration; 2003; 70(4):408-13. PubMed ID: 14512678
[TBL] [Abstract][Full Text] [Related]
2. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group.
Pietinalho A; Tukiainen P; Haahtela T; Persson T; Selroos O
Chest; 1999 Aug; 116(2):424-31. PubMed ID: 10453872
[TBL] [Abstract][Full Text] [Related]
3. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
[TBL] [Abstract][Full Text] [Related]
4. Role of serial F-18 FDG PET/CT scans in assessing treatment response and predicting relapses in patients with symptomatic sarcoidosis.
Maturu VN; Rayamajhi SJ; Agarwal R; Aggarwal AN; Gupta D; Mittal BR
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):372-380. PubMed ID: 28079849
[TBL] [Abstract][Full Text] [Related]
5. Inhaled corticosteroids for maintenance treatment in childhood pulmonary sarcoidosis.
Kiper N; Anadol D; Ozçelik U; Göçmen A
Acta Paediatr; 2001 Aug; 90(8):953-6. PubMed ID: 11529550
[TBL] [Abstract][Full Text] [Related]
6. Oral and inhaled corticosteroids in the treatment of pulmonary sarcoidosis--a critical reappraisal.
Milman N
Sarcoidosis Vasc Diffuse Lung Dis; 1998 Sep; 15(2):150-7. PubMed ID: 9789893
[TBL] [Abstract][Full Text] [Related]
7. Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis.
Bolat S; Berding G; Dengler R; Stangel M; Trebst C
J Neurol Sci; 2009 Dec; 287(1-2):257-9. PubMed ID: 19755199
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis.
Yamada Y; Uchida Y; Tatsumi K; Yamaguchi T; Kimura H; Kitahara H; Kuriyama T
J Nucl Med; 1998 Jul; 39(7):1160-6. PubMed ID: 9669387
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis.
Keijsers RG; Verzijlbergen EJ; van den Bosch JM; Zanen P; van de Garde EM; Oyen WJ; Grutters JC
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):123-9. PubMed ID: 22117503
[TBL] [Abstract][Full Text] [Related]
10. [A case of sub-acute onset pulmonary sarcoidosis with pulmonary dysfunction].
Saito H; Ikehara M; Komase Y; Omiya S; Nakagawa T
Nihon Kokyuki Gakkai Zasshi; 2005 Apr; 43(4):225-30. PubMed ID: 15966369
[TBL] [Abstract][Full Text] [Related]
11. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
[TBL] [Abstract][Full Text] [Related]
12. Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.
Milman N; Graudal N; Loft A; Mortensen J; Larsen J; Baslund B
Clin Respir J; 2012 Oct; 6(4):238-47. PubMed ID: 22128762
[TBL] [Abstract][Full Text] [Related]
13. Chronic eosinophilic pneumonia: treatment with inhaled corticosteroids.
Minakuchi M; Niimi A; Matsumoto H; Amitani R; Mishima M
Respiration; 2003; 70(4):362-6. PubMed ID: 14512670
[TBL] [Abstract][Full Text] [Related]
14. [Inhaled corticosteroids in idiopathic pulmonary hemosiderosis: 2 cases].
Ben Halima N; Karray A; Krichen A; Feki H; Ben Salah M; Chabchoub I; Hachicha M; Mahfoudh A; Triki A
Tunis Med; 2003 Apr; 81(4):283-7. PubMed ID: 12848014
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary sarcoidosis: an update.
Ramachandraiah V; Aronow W; Chandy D
Postgrad Med; 2017 Jan; 129(1):149-158. PubMed ID: 27766929
[TBL] [Abstract][Full Text] [Related]
16. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.
Teirstein AS; Machac J; Almeida O; Lu P; Padilla ML; Iannuzzi MC
Chest; 2007 Dec; 132(6):1949-53. PubMed ID: 17925421
[TBL] [Abstract][Full Text] [Related]
17. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
[TBL] [Abstract][Full Text] [Related]
18. Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease.
Nishimura K; Ikeda A; Koyama H; Zhang M; Tsukino M; Hajiro T; Izumi T
Pulm Pharmacol Ther; 2000; 13(5):225-30. PubMed ID: 11001866
[TBL] [Abstract][Full Text] [Related]
19. Early treatment of stage II sarcoidosis improves 5-year pulmonary function.
Pietinalho A; Tukiainen P; Haahtela T; Persson T; Selroos O;
Chest; 2002 Jan; 121(1):24-31. PubMed ID: 11796428
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis.
Vorselaars AD; Crommelin HA; Deneer VH; Meek B; Claessen AM; Keijsers RG; van Moorsel CH; Grutters JC
Eur Respir J; 2015 Jul; 46(1):175-85. PubMed ID: 25929955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
